Neurology News

LAS VEGAS — Clinicians should make specific product recommendations to patients for over-the-counter topical pain medications to help prevent confusion among hundreds of analgesic choices at the pharmacy.

In this edition, blood-based concussion diagnostic tool gets patent; examining the brain’s electrical signals may be key to treating epilepsy, schizophrenia; machine-learning model may predict best antiseizure medications and more.

LAS VEGAS — Antihistamines are not always the answer for pruritis in pain and advanced illness, Laura Meyer-Junco, PharmD, BCPS, CPE, said during a presentation at PAINWeek 2022.

Levetiracetam was safe and may be effective in preventing acute seizures in patients with spontaneous intracerebral hemorrhage, according to clinical trial results in The Lancet Neurology.

After 2 years of virtual meetings, the fourth annual Women in Medicine Summit will be taking place in person in Chicago from Sept. 16 to 17.

LAS VEGAS — The majority of opioid-related overdoses can be linked to illicit heroin and fentanyl, not opioids prescribed by physicians to patients with legitimate chronic pain, according to a presentation during PAINWeek 2022.

LAS VEGAS — Recognition of the fear avoidance model, which is how one develops chronic pain through avoidant behavior, can help clinicians treat pain in patients, according to a presenter at PAINWeek 2022.

LAS VEGAS — Lesser-known cannabinoids are showing potential for treating neurological disease, inflammation, pain, cancer and infection, according to dermatologist Jeanette Jacknin, MD.

Asundexian on top of dual antiplatelet therapy successfully reduced factor XIa activity after acute MI and stroke with no excess bleeding risk, two speakers reported.

Cerveau Technologies Inc. announced a partnership with Alnylam Pharmaceuticals, which will use Cerveau’s investigational imaging agent in positron emission tomography scans to evaluate neurofibrillary tangles in the brain.